BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33104171)

  • 1. Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling.
    Wang L; Luo Y; Luo L; Wu D; Ding X; Zheng H; Wu H; Liu B; Yang X; Silva F; Wang C; Zhang X; Zheng X; Chen J; Brigman J; Mandell M; Zhou Z; Liu F; Yang XO; Liu M
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33104171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
    Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
    Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
    [No Abstract]   [Full Text] [Related]  

  • 3. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
    Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
    Front Immunol; 2021; 12():664218. PubMed ID: 34867937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
    Symowski C; Voehringer D
    Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLAM-family receptors promote resolution of ILC2-mediated inflammation.
    Wang Y; Quan Y; He J; Chen S; Dong Z
    Nat Commun; 2024 Jun; 15(1):5056. PubMed ID: 38871792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33 causes thermogenic failure in aging by expanding dysfunctional adipose ILC2.
    Goldberg EL; Shchukina I; Youm YH; Ryu S; Tsusaka T; Young KC; Camell CD; Dlugos T; Artyomov MN; Dixit VD
    Cell Metab; 2021 Nov; 33(11):2277-2287.e5. PubMed ID: 34473956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue.
    Fali T; Aychek T; Ferhat M; Jouzeau JY; Busslinger M; Moulin D; Eberl G
    Mucosal Immunol; 2021 May; 14(3):585-593. PubMed ID: 33106586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33.
    Lownik JC; Conrad DH; Martin RK
    Biochem Biophys Res Commun; 2019 May; 512(4):723-728. PubMed ID: 30926166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity.
    Ding X; Luo Y; Zhang X; Zheng H; Yang X; Yang X; Liu M
    J Endocrinol; 2016 Oct; 231(1):35-48. PubMed ID: 27562191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prostaglandin D
    Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
    J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
    Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
    Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
    Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
    J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E
    Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
    Front Immunol; 2018; 9():501. PubMed ID: 29593738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17-producing ST2
    Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
    J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Rel Is Required for IL-33-Dependent Activation of ILC2s.
    Zaini A; Fulford TS; Grumont RJ; Runting J; Rodrigues G; Ng J; Gerondakis S; Zaph C; Scheer S
    Front Immunol; 2021; 12():667922. PubMed ID: 34194431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity.
    Zhang J; Qiu J; Zhou W; Cao J; Hu X; Mi W; Su B; He B; Qiu J; Shen L
    Nat Immunol; 2022 Feb; 23(2):237-250. PubMed ID: 35075279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Globular Adiponectin Inhibits Lipopolysaccharide-Primed Inflammasomes Activation in Macrophages via Autophagy Induction: The Critical Role of AMPK Signaling.
    Kim MJ; Kim EH; Pun NT; Chang JH; Kim JA; Jeong JH; Choi DY; Kim SH; Park PH
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor.
    Xiao Q; Han X; Liu G; Zhou D; Zhang L; He J; Xu H; Zhou P; Yang Q; Chen J; Zhou J; Jiang G; Yao Z
    Mucosal Immunol; 2022 Feb; 15(2):338-350. PubMed ID: 34921233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.